Filter
2703
Filtered Results: 2703
Text search:
vaccination
programme
Featured
Recommendations
270
New Publications
761
Language
Document type
No document type
1439
Studies & Reports
468
Guidelines
344
Strategic & Response Plan
164
Manuals
133
Fact sheets
60
Situation Updates
45
Training Material
28
Brochures
7
Resource Platforms
7
Infographics
5
Online Courses
3
Countries / Regions
Global
113
Congo, Democratic Republic of
110
India
92
Senegal
75
Kenya
68
Sierra Leone
56
Benin
49
Burkina Faso
47
Nepal
46
South Africa
46
Liberia
46
Western and Central Europe
44
Nigeria
43
Africa
42
Uganda
39
Ethiopia
39
Syria
38
Haiti
33
Tanzania
33
Bangladesh
32
South Sudan
31
Cameroon
29
Ukraine
28
Ghana
27
Zambia
26
Rwanda
25
Malawi
25
Guinea
25
Myanmar / Burma
25
Central African Republic
24
Madagascar
24
Zimbabwe
21
Namibia
20
Mozambique
18
Latin America and the Carribbean
18
South–East Asia Region
18
Lesotho
17
Eastern Europe
17
Yemen
14
Mali
14
Pakistan
14
West and Central Africa
13
East and Southern Africa
13
Niger
12
Cambodia
12
Togo
11
Western Pacific Region
11
Venezuela
10
Middle East and North Africa
10
Eastern Europe and Central Asia
10
Sudan
10
Afghanistan
9
Philippines
9
Asia
8
Jordan
8
Lebanon
8
Chad
8
Indonesia
8
Somalia
8
Germany
7
Côte d’Ivoire / Ivory Coast
6
Brazil
6
Botswana
6
Colombia
5
Iraq
5
Burundi
4
Palestine
4
Eswatini/ Swaziland
4
Thailand
3
Laos
3
Peru
3
Mauritius
3
Vietnam
3
Moldova
3
Sri Lanka
3
Russia
3
Poland
3
Tajikistan
2
Turkey
2
Chile
2
Iran
2
Albania
2
Fiji
2
Morocco
2
Bulgaria
2
Hungary
2
Saudi Arabia
2
Jamaica
2
France
2
Tunisia
2
Papua New Guinea
2
Egypt
2
Georgia
2
Libya
2
North Macedonia
1
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Uzbekistan
1
Malaysia
1
Qatar
1
Mauritania
1
USA
1
Paraguay
1
Gabon
1
Denmark
1
Maldives
1
Bolivia
1
Argentina
1
Djibouti
1
Romania
1
Slovakia
1
Angola
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1162
Clinical Guidelines
231
Women & Child Health
174
Public Health
155
Key Resources
113
Capacity Building
29
Pharmacy & Technologies
18
Toolboxes
COVID-19
322
TB
141
HIV
131
Rapid Response
129
AMR
99
Conflict
93
Ebola
84
Planetary Health
65
Mental Health
59
Caregiver
53
Refugee
52
Disability
49
Polio
48
NTDs
40
Global Health Education
36
Natural Hazards
31
Health Financing Toolbox
30
Cholera
28
Pharmacy
27
NCDs
24
Zika
11
Specific Hazards
3
Typhoon
3
South Sudan
2
Health Financing
1
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall...
Strategic communication is at the heart of public health and more important than ever in the digital age. Using communication strategically requires expertise, skills and resources to plan, implement and evaluate interventions that encourage governments to implement policies that improve people’s ...
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
Le document, intitulé « Progrès dans la prévention et le contrôle des maladies non transmissibles », rend compte des efforts mondiaux pour réduire l’impact des MNT (maladies non transmissibles), telles que les maladies cardiaques, le cancer, le diabète et les maladies respiratoires chroniq...
The "Stories from the field" document by the WHO Regional Office for the Eastern Mediterranean shares effective strategies from the Eastern Mediterranean Region for addressing noncommunicable diseases (NCDs) and mental health challenges, particularly during the COVID-19 pandemic. It highlights regio...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
Risk factors for asthma among schoolchildren who participated in a casecontrol study in urban Uganda
Data on asthma aetiology in Africa are scarce. We investigated the risk factors for asthma among schoolchildren (5–17 years) in urban Uganda. We conducted a case-control study, among 555 cases and 1115 controls. Asthma was diagnosed by study clinicians. The main risk factors for asthma were tertia...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
